Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Diagnostic Yield and Implications of Targeted Founder Pathogenic Variant Testing in an Israeli Cohort. | Cancers (Basel) | 2023 | 38201524 | PubTator, text mining | PubMed |
| Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis. | Cancers (Basel) | 2023 | 38201513 | PubTator, text mining | PubMed |
| Exploiting the DNA Damage Response for Prostate Cancer Therapy. | Cancers (Basel) | 2023 | 38201511 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cell Markers in Ovarian Cancer. | Cancers (Basel) | 2023 | 38201468 | PubTator, text mining | PubMed |
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| Genetic contribution of breast cancer genes in women of black African origin. | Front Genet | 2023 | 38192440 | PubTator, text mining | PubMed |
| Genetic Testing for Successful Cancer Treatment. | Cureus | 2023 | 38179395 | PubTator, text mining | PubMed |
| Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. | Cureus | 2023 | 38161833 | PubTator, text mining | PubMed |
| Superfamily II helicases: the potential therapeutic target for cardiovascular diseases. | Front Cardiovasc Med | 2023 | 38152606 | PubTator, text mining | PubMed |
| TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism. | Front Oncol | 2023 | 38152367 | PubTator, text mining | PubMed |
| The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations. | Front Oncol | 2023 | 38146508 | PubTator, text mining | PubMed |
| Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome. | Cancers (Basel) | 2023 | 38136308 | PubTator, text mining | PubMed |
| Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. | Cancers (Basel) | 2023 | 38136276 | PubTator, text mining | PubMed |
| Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. | Cancers (Basel) | 2023 | 38136262 | PubTator, text mining | PubMed |
| Beyond the exome: utility of long-read whole genome sequencing in exome-negative autosomal recessive diseases. | Genome Med | 2023 | 38098057 | PubTator, text mining | PubMed |
| The Novel Use of Magtrace in Chest Masculinizing Transgender Top Surgery. | Plast Reconstr Surg Glob Open | 2023 | 38093726 | PubTator, text mining | PubMed |
| Personalized medicine in a community health system: the NorthShore experience. | Front Genet | 2023 | 38090148 | PubTator, text mining | PubMed |
| Variantes genéticas recurrentes y priorización de variantes de significado clínico desconocido asociadas al síndrome de cáncer de mama y ovario hereditario en familias de la Región de Murcia. | Adv Lab Med | 2023 | 38075173 | PubTator, text mining | PubMed |
| Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia. | Adv Lab Med | 2023 | 38075165 | PubTator, text mining | PubMed |
| Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer. | Sci Rep | 2023 | 38072854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=15